19.56
price up icon2.14%   0.41
after-market After Hours: 19.56
loading
Oculis Holding Ag stock is traded at $19.56, with a volume of 34,216. It is up +2.14% in the last 24 hours and up +5.33% over the past month. Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
See More
Previous Close:
$19.15
Open:
$19.34
24h Volume:
34,216
Relative Volume:
0.92
Market Cap:
$938.88M
Revenue:
-
Net Income/Loss:
$-75.28M
P/E Ratio:
-9.8011
EPS:
-1.9957
Net Cash Flow:
$-57.45M
1W Performance:
+0.31%
1M Performance:
+5.33%
6M Performance:
+25.79%
1Y Performance:
+63.68%
1-Day Range:
Value
$19.16
$19.60
1-Week Range:
Value
$19.00
$19.82
52-Week Range:
Value
$10.79
$23.08

Oculis Holding Ag Stock (OCS) Company Profile

Name
Name
Oculis Holding Ag
Name
Phone
-
Name
Address
-
Name
Employee
49
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
OCS's Discussions on Twitter

Compare OCS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
OCS
Oculis Holding Ag
19.56 1.02B 0 -75.28M -57.45M -1.9957
Biotechnology icon
ONC
Beone Medicines Ltd Adr
257.00 26.69B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
443.82 114.81B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.282 41.83M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
85.54 6.60B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
483.07 65.36B 14.09B 4.50B 2.96B 39.28

Oculis Holding Ag Stock (OCS) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-05-23 Initiated Chardan Capital Markets Buy
Oct-05-23 Initiated Stifel Buy
Jun-14-23 Initiated BofA Securities Buy
Jun-12-23 Initiated H.C. Wainwright Buy
Jun-08-23 Initiated Robert W. Baird Outperform
May-10-23 Initiated Pareto Buy
Apr-28-23 Initiated Wedbush Outperform
View All

Oculis Holding Ag Stock (OCS) Latest News

pulisher
Jun 05, 2025

Oculis Holding AG Announces 2025 AGM Results and Strategic Approvals - TipRanks

Jun 05, 2025
pulisher
Jun 05, 2025

Leerink Partners raises Oculis stock price target to $50 from $22 - Investing.com

Jun 05, 2025
pulisher
Jun 05, 2025

Oculis Holding AG Reports Outcomes of 2025 Annual General Meeting and Shareholder Approvals - Nasdaq

Jun 05, 2025
pulisher
Jun 05, 2025

Oculis Publishes Results of 2025 Annual General Meeting - The Manila Times

Jun 05, 2025
pulisher
Jun 05, 2025

REG-Oculis Publishes Results of 2025 Annual General Meeting - TradingView

Jun 05, 2025
pulisher
Jun 04, 2025

Citadel Advisors LLC Buys Shares of 22,911 Oculis Holding AG (NASDAQ:OCS) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities - GlobeNewswire Inc.

Jun 03, 2025
pulisher
Jun 03, 2025

Oculis to Participate in Upcoming June Investor Conferences - InvisionMag.com

Jun 03, 2025
pulisher
Jun 03, 2025

Oculis Holding AG Announces Participation in Upcoming Investor Conferences in June 2025 - Nasdaq

Jun 03, 2025
pulisher
May 27, 2025

Trend Tracker for (OCS) - news.stocktradersdaily.com

May 27, 2025
pulisher
May 19, 2025

Trend Tracker for (OCSAW) - news.stocktradersdaily.com

May 19, 2025
pulisher
May 15, 2025

HC Wainwright Estimates Oculis’ Q2 Earnings (NASDAQ:OCS) - Defense World

May 15, 2025
pulisher
May 15, 2025

HC Wainwright Weighs in on Oculis’ Q1 Earnings (NASDAQ:OCS) - Defense World

May 15, 2025
pulisher
May 13, 2025

Oculis (NASDAQ:OCS) Sees Large Volume Increase on Analyst Upgrade - Defense World

May 13, 2025
pulisher
May 12, 2025

Oculis (NASDAQ:OCS) Price Target Raised to $33.00 - Defense World

May 12, 2025
pulisher
May 10, 2025

Oculis Publishes Invitation to the Annual General Meeting - The Manila Times

May 10, 2025
pulisher
May 09, 2025

Oculis Holding AG (OCS) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 09, 2025
pulisher
May 09, 2025

Oculis Announces 2025 Annual General Meeting Details - TipRanks

May 09, 2025
pulisher
May 09, 2025

Dave To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga

May 09, 2025
pulisher
May 09, 2025

Oculis Reports Q1 2025 Financial Results and Provides Company Update - The Manila Times

May 09, 2025
pulisher
May 09, 2025

Oculis Holding AG Reports Strong Q1 Progress - TipRanks

May 09, 2025
pulisher
May 09, 2025

Learn to Evaluate (OCSAW) using the Charts - news.stocktradersdaily.com

May 09, 2025
pulisher
May 09, 2025

Earnings Preview: Oculis Holding AG (OCS) Q1 Earnings Expected to Decline - MSN

May 09, 2025
pulisher
May 08, 2025

Oculis Holding AG reports results for the quarter ended March 31Earnings Summary - TradingView

May 08, 2025
pulisher
May 08, 2025

Oculis Holding AG Reports Q1 2025 Financial Results - TipRanks

May 08, 2025
pulisher
May 07, 2025

Oculis to Present at Upcoming May Investor Conferences - EIN News

May 07, 2025
pulisher
May 07, 2025

REG-Oculis to Present at Upcoming May Investor Conferences - TradingView

May 07, 2025
pulisher
May 06, 2025

Long Term Trading Analysis for (OCS) - news.stocktradersdaily.com

May 06, 2025
pulisher
May 04, 2025

Oculis (NASDAQ:OCS) Sees Unusually-High Trading Volume – Still a Buy? - Defense World

May 04, 2025
pulisher
May 04, 2025

Oculis Holding AG (NASDAQ:OCS) Shares Bought by Geode Capital Management LLC - Defense World

May 04, 2025
pulisher
May 01, 2025

Oculis to Present its Innovative Late-Stage Pipeline Candidates at Upcoming Ophthalmology Conferences - The Manila Times

May 01, 2025
pulisher
May 01, 2025

Oculis Holding AG to Present Innovative Late-Stage Pipeline at Major Ophthalmology Conferences in 2025 - Nasdaq

May 01, 2025
pulisher
May 01, 2025

Oculis Holding AG to Present Innovative Late-Stage Pipeline at Major Ophthalmology Conferences in May 2025 - Nasdaq

May 01, 2025
pulisher
Apr 26, 2025

Oculis Updates Share Capital - The Manila Times

Apr 26, 2025
pulisher
Apr 23, 2025

Long Term Trading Analysis for (OCSAW) - news.stocktradersdaily.com

Apr 23, 2025
pulisher
Apr 20, 2025

(OCS) Trading Advice - news.stocktradersdaily.com

Apr 20, 2025
pulisher
Apr 19, 2025

Chardan Capital Reaffirms Buy Rating for Oculis (NASDAQ:OCS) - Defense World

Apr 19, 2025
pulisher
Apr 19, 2025

HC Wainwright Increases Oculis (NASDAQ:OCS) Price Target to $32.00 - Defense World

Apr 19, 2025
pulisher
Apr 18, 2025

Oculis (NASDAQ:OCS) Shares Gap Up Following Analyst Upgrade - Defense World

Apr 18, 2025
pulisher
Apr 17, 2025

Oculis and EURETINA Announce the 2025 Ramin Tadayoni Award - The Manila Times

Apr 17, 2025
pulisher
Apr 15, 2025

Stifel maintains Buy rating, $35 target on Oculis shares By Investing.com - Investing.com South Africa

Apr 15, 2025
pulisher
Apr 15, 2025

Stifel maintains Buy rating, $35 target on Oculis shares - Investing.com

Apr 15, 2025
pulisher
Apr 15, 2025

Oculis Holding AG Unveils Key Clinical Updates and Future Outlook at R&D Day - TipRanks

Apr 15, 2025
pulisher
Apr 15, 2025

Oculis Hosts R&D Event Today to Showcase Progress on All Three Pipeline Assets - The Manila Times

Apr 15, 2025
pulisher
Apr 11, 2025

Oculis completes enrolment in trials for diabetic macular oedema eye drops - Yahoo

Apr 11, 2025
pulisher
Apr 10, 2025

Oculis completes enrollment for pivotal DME treatment trials By Investing.com - Investing.com South Africa

Apr 10, 2025

Oculis Holding Ag Stock (OCS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$1.15
price down icon 0.86%
$580.59
price up icon 1.24%
$308.00
price up icon 0.88%
$36.54
price up icon 1.27%
$4.8111
price up icon 1.29%
$483.07
price down icon 0.38%
Cap:     |  Volume (24h):